Company Profile

Renalytix plc (NASDAQ: RNLX)
5:30 PM UTC, 07/03/24
Last: $0.25 Change: -0.00 %Change: -1.15% Volume: 91,841
Detailed Quote
Open: $ 0.25   Volume: 91,841
High: $ 0.25   Yield(%) 0.00
Low: $ 0.25   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 19.30M
EPS ($) -0.78   Shares Out: 77.18M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -43.96
% Price Change (last 13 weeks): -70.26
% Price Change (last 26 weeks): -40.52
% Price Change (last 52 weeks): -91.82
% Price Change (year to date): -35.90
Management Effectiveness
Return on Equity (%): -242.76
Return on Assets (%): -113.04
Return on Invested Capital (%): -94.80
Profitability
Gross Profit Margin (%): 21.16
Net Profit Margin (%): -1340.20
Operating Profit Margin (%): -1240.70
Price & Volume
50-day Moving Average: $0.51
200-day Moving Average: $0.76
Avg. Daily Vol. (last 50 days): 336,878
Avg. Daily Vol. (last 200 days): 750,651
52-wk high: $4.04
52-wk low: $0.22
Bid: $0.25
Ask: $0.25
Company Information
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Renalytix plc
1460 Broadway
New York NY 10036

Phone: 1.646.397.3970
Fax: n/a
http://www.renalytixai.com
Per Share Data
Earnings (1year) ($): -0.78
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.15
Cash Flow ($): -0.96
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 35.27
Price/Book (x): 19.65
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 1.67
Current Ratio (x): 1.67
LT Debt/Equity (x): 108.02
Total Debt/Equity (x): 173.95



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.